Influence of hyperhomocysteinemia on left ventricular diastolic function in Chinese patients with hypertension;Einfluss der Hyperhomozysteinämie auf die linksventrikuläre diastolische Funktion bei chinesischen Hypertoniepatienten

Herz

Volumn 40, Issue 4, 2015, Pages 679-684

  Ruhui, L ^a   Jinfa, J ^a   Jiahong, X ^a   Wenlin, M ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Color Doppler echocardiography; Doppler pulsed echocardiography; Homocysteine; Left ventricular diastolic function; Prospective study

Indexed keywords

ANTIHYPERTENSIVE AGENT; HOMOCYSTEINE; BIOLOGICAL MARKER;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BODY MASS; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHINESE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DECELERATION TIME; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRUG USE; EARLY DIASTOLIC TRANSMITRAL VELOCITY EARLY DIASTOLIC TISSUE VELOCITY RATIO; EARLY LATE MITRAL INFLOW VELOCITY RATIO; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; ISOVOLUMIC RELAXATION TIME; LEFT ATRIAL LENGTH; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LEFT VENTRICULAR END DIASTOLIC DIAMETER; LEFT VENTRICULAR END SYSTOLIC DIAMETER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; SYSTOLIC BLOOD PRESSURE; BLOOD; CAUSALITY; CHINA; COMORBIDITY; HEART LEFT VENTRICLE FUNCTION; INCIDENCE; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

BIOMARKERS; CAUSALITY; CHINA; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84931009659     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-014-4098-x     Document Type: Article

References (53)

1. Gandhi SK, Powers JC, Nomeir AM et al (2001) The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 344:17–22
2. Vasan RS, Benjamin EJ (2001) Diastolic heart failure-no time to relax. N Engl J Med 344:56–59
3. Qu P, Ding Y, Xia D et al (2001) Variations in cardiac diastolic function in hypertensive patients with different left ventricular geometric patterns. Hypertens Res 24:601–604
4. Little WC, Ohno M, Kitzman DW et al (1995) Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling. Circulation 92:1933–1939
5. Wachtell K, Bella JN, Rokkedal J et al (2002) Change in diastolic left ventricular filling after one year of antihypertensive treatment. The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study. Circulation 105:1071–1076
6. Takamura T, Onishi K, Sugimoto T et al (2008) Patients with a hypertensive response to exercise have impaired left ventricular diastolic function. Hypertens Res 31:257–263
7. Jiang Y, Xia X, Wang W et al (2012) Hyperhomocysteinemia and related genetic polymorphisms correlate with ulcerative colitis in Chinese Han population in Central China. Cell Biochem Biophys 62:203–210
8. Stanger O, Weger M (2003) Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium. Clin Chem Lab Med 41:1444–1454
9. Toole JF, Malinow MR, Chambless LE et al (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized trial. JAMA 291:565–575
10. Jakubowski H (2008) The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J Physiol Pharmacol 59(Suppl 9):155–167
11. Dayal S, Lentz SR (2008) Murine models of hyperhomocysteinemia and their vascular phenotypes. Arterioscler Thromb Vasc Biol 28:1596–1605
12. Tyagi SC (1998) Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells. Am J Physiol 274:C396–C405
13. Pezzini A, Del Zotto E, Padovani A (2007) Homocysteine and cerebral ischemia: pathogenic and therapeutical implications. Curr Med Chem 14:249–263
14. Nittynen L, Nurminen ML, Korpela R, Vapaatalo H (1999) Role of arginine, taurine and homocysteine in cardiovascular diseases. Ann Med 31:318–326
15. Rodrigo R, Passalacqua W, Araya J et al (2003) Homocysteine and essential hypertension. J Clin Pharmacol 43:1299–1306
16. Lip GY, Edmunds E, Martin SC et al (2001) A pilot study of homocyst(e)ine levels in essential hypertension: relationship to von Willebrand factor, an index of endothelial damage. Am J Hypertens 14:627–631
17. Sainani GS, Sainani R (2002) Homocysteine and its role in the pathogenesis of atherosclerotic vascular disease. J Assoc Physicians India 50(Suppl):16–23
18. Galderisi M (2005) Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects. Cardiovasc Ultrasound 3:9
19. Swedberg K, Cleland J, Dargie H et al (2005) Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26:1115–1140
20. Nieminen MS, Böhm M, Cowie MR et al (2005) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26:384–416
21. Maurer MS, Spevack D, Burkhoff D, Kronzon I (2004) Diastolic dysfunction: can it be diagnosed by Doppler echocardiography? J Am Coll Cardiol 44:1543–1549
22. Oh JK, Hatle L, Tajik AJ, Little WC (2006) Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography. J Am Coll Cardiol 47:500–506
23. Gottdiener JS, Bednarz J, Devereux R et al (2004) American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 17:1086–1119
24. Bess RL, Khan S, Rosman HS et al (2006) Technical aspects of diastology: why mitral inflow and tissue Doppler imaging are the preferred parameters? Echocardiography 23:332–339
25. Ishida Y, Meisner JS, Tsujioka K et al (1986) Left ventricular filling dynamics: influence of left ventricular relaxation and left atrial pressure. Circulation 74:187–196
26. Choong CY, Abascal VM, Thomas JD et al (1988) Combined influence of ventricular loading and relaxation on the transmitral flow velocity profile in dogs measured by Doppler echocardiography. Circulation 78:672–683
27. Thomas JD, Choong CY, Flachskampf FA, Weyman AE (1990) Analysis of the early transmitral Doppler velocity curve: effect of primary physiologic changes and compensatory preload adjustment. J Am Coll Cardiol 16:644–655
28. Sohn DW, Chai IH, Lee DJ et al (1997) Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 30:474–480
29. Ommen SR, Nishimura RA, Appleton CP et al (2000) Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102:1788–1794
30. Nagueh SF, Sun H, Kopelen HA et al (2001) Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. J Am Coll Cardiol 37:278–285
31. Arques S (2003) Usefulness of combined Doppler indexes in predicting left ventricular filling pressures in patients with acute heart failure. Am J Cardiol 92:649–650
32. Gonzalez-Vilchez F, Ayuela J, Ares M et al (2002) Comparison of Doppler echocardiography, color M-mode Doppler, and Doppler tissue imaging for the estimation of pulmonary capillary wedge pressure. J Am Soc Echocardiogr 15:1245–1250
33. Rivas-Gotz C, Manolios M, Thohan V, Nagueh SF (2003) Impact of left ventricular ejection fraction on estimation of left ventricular filling pressures using tissue Doppler and flow propagation velocity. Am J Cardiol 91:780–784
34. Dokainish H, Zoghbi WA, Lakkis NM et al (2004) Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation 109:2432–2439
35. Bruch C, Stypmann J, Grude M et al (2004) Tissue Doppler imaging in patients with moderate to severe aortic valve stenosis: clinical usefulness and diagnostic accuracy. Am Heart J 148:696–702
36. Bruch C, Grude M, Muller J et al (2005) Usefulness of tissue Doppler imaging for estimation of left ventricular filling pressures in patients with systolic and diastolic heart failure. Am J Cardiol 95:892–895
37. Hadano Y, Murata K, Liu J et al (2005) Can transthoracic Doppler echocardiography predict the discrepancy between left ventricular end-diastolic pressure and mean pulmonary capillary wedge pressure in patients with heart failure? Circ J 69:432–438
38. Paelinck BP, Roos A de, Bax JJ et al (2005) Feasibility of tissue magnetic resonance imaging: a pilot study in comparison with tissue Doppler imaging and invasive measurement. J Am Coll Cardiol 45:1109–1116
39. Arques S, Roux E, Luccioni R (2007) Current clinical applications of spectral tissue Doppler echocardiography (E/e’ ratio) as a noninvasive surrogate for left ventricular diastolic pressures in the diagnosis of heart failure with preserved left ventricular systolic function. Cardiovasc Ultrasound 5:16–28
40. Bursi F, Weston SA, Redfield MM et al (2006) Systolic and diastolic heart failure in the community. JAMA 296:2209–2216
41. Kim YJ, Sohn DW (2000) Mitral annulus velocity in the estimation of left ventricular filling pressure: prospective study in 200 patients. J Am Soc Echocardiogr 13:980–985
42. Kasner M, Westermann D, Steendijk P et al (2007) Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation 11:637–647
43. Nagueh SF, Appleton CP, Gillebert CT et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107–133
44. Welch GN, Upchurch G Jr, Loscalzo J (1997) Hyperhomocyst(e)inemia and atherothrombosis. Ann N Y Acad Sci 811:48–58
45. Andersson A, Lindgren A, Hultberg B (1995) Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction. Clin Chem 41:361–366
46. Starkebaum G, Harlan JM (1986) Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 77:1370–1376
47. Celermajer DS, Sorensen K, Ryalls M et al (1993) Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol 22:854–858
48. Stamler JS, Osborne JA, Jaraki O et al (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91:308–318
49. Reddy HK, Tjahja IE, Campbell SE et al (2004) Expression of matrix metalloproteinase activity in idiopathic dilated cardiomyopathy: a marker of cardiac dilatation. Mol Cell Biochem 264:183–191
50. Alter P, Rupp H, Rominger MB et al (2010) Association of hyperhomocysteinemia with left ventricular dilatation and mass in human heart. Clin Chem Lab Med 48:555–560
51. Au-Yeung KK, Woo CW, Sung FL et al (2004) Hyperhomocysteinemia activates nuclear factor-kappaB in endothelial cells via oxidative stress. Circ Res 94:28–36
52. Badiou S, Dupuy AM, Jaussent I et al (2012) Homocysteine as a determinant of left ventricular ejection fraction in patients with diabetes. Clin Chem Lab Med 50:1099–1106
53. Peer M, Boaz M, Zipora M, Shargorodsky M (2013) Determinants of left ventricular hypertrophy in hypertensive patients: identification of high-risk patients by metabolic, vascular, and inflammatory risk factors. Int J Angiol 22:223–228